Review of perioperative management of anticoagulant and antiplatelet therapy
DOI:
https://doi.org/10.30445/rear.v14i12.1063Keywords:
Anticoagulants, antiplatelets, perioperative, hemorrhage, trombotic riskAbstract
Many drugs are important at perioperative context. Anticoagulants and antiplatelet are two of the most problematic and risky drugs during surgery if they are not correctly managed, due to the difficult balance between thrombotic and hemorrhagic risk. Even more, the increase in the use of these drugs emphasizes the importance of the constant review and actualization of our attitude towards pre, intra and postoperative use of them in this context.
This review is based on the recomendations from the last consensus document of the Grupo de Trabajo de Trombosis Cardiovascular of Spanish Society of Cardiology, recognized by a wide range of scientific societies who participe allong the perioperative period including in one document the most relevant and actualized information.
References
- HEMOSTASIA; J. Alonso, A. Fernández, A. Arízaga, L. Aguilera; Fisiología Aplicada a la Anestesiología, 3ª edición.
- Manejo Perioperatorio y Periprocedimiento del Tratamiento Antitrombótico: documento de consenso de SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT, AEU.
- Protocolo de tromboprofilaxis del Hospital Universitario de Getafe (2021).
- Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy, American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (4th edition).
- Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO), The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC), and of the European Society for Vascular Surgery.
- M. Roffi, C. Patrono, J.P. Collet, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J., 37 (2016), pp. 267-315.
- G.N. Levine, E.R. Bates, J.A. Bittl, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. Circulation., 134 (2016), pp. e123-e155.
- Jiménez-Quevedo, A. Serrador, A. Pérez de Prado, M. Pan. Registro Español de Hemodinámica y Cardiología Intervencionista. XXV Informe Oficial de la Sección de Hemodinámica y Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2015). Rev Esp Cardiol., 69 (2016), pp. 1180-1189.
- A.C. Spyropoulos, A. Al-Badri, M.W. Sherwood, J.D. Douketis. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.
- P.B. Berger, N.S. Kleiman, M.J. Pencina, et al. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. JACC Cardiovasc Interv., 9 (2010), pp. 920-927.
- F. Hidalgo, A. Gómez-Luque, R. Ferrandis, et al. Perioperative management of direct oral anticoagulant in emergency surgery and bleeding. Haemostasis monitoring and treatment. Rev Esp Anestesiol Reanim., 62 (2015), pp. 450-460.
- D. Faraoni, J.H. Levy, P. Albaladejo, C.M. Samama. Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants. Crit Care., 19 (2015), pp. 203.
- D. Douketis, A.C. Spyropoulos, S. Kaatz, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med., 373 (2015), pp. 823-833.
- J. Hirsh, V. Fuster, J. Ansell, J.L. Halperin. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation., 107 (2003), pp. 1692-1711.
- J.H. Levy. Discontinuation and management of direct-acting anticoagulants for emergency procedures. Am J Emerg Med., 34 (2016), pp. 14-18.
- M.J. Colomina, A. Díez Lobo, I. Garutti, A. Gómez-Luque, J.V. Llau, E. Pita. Perioperative use of prothrombin complex concentrates. Minerva Anestesiol., 78 (2012), pp. 358-368.
- J.V. Llau, C. Lopez-Forte, L. Sapena, R. Ferrandis. Perioperative management of antiplatelet agents in noncardiac surgery. Eur J Anaesthesiol., 26 (2009), pp. 181-187.
- Patrono C, Baigent C, Hirsh J, Roth G. Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:199S-233S.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Electrónica AnestesiaR
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Envío y derechos de autor
Revista Electrónica AnestesiaR by 